Epitalon

A synthetic tetrapeptide discussed in longevity circles and studied mainly in older or limited research settings.

Commonly discussed or studied in relation to:

Epitalon appears often in longevity conversations because of older research exploring aging-related biology.

Available research is limited, older, and often difficult to independently verify or replicate.

Human research: Very limited human data.

Not an approved treatment in the United States.

Approval for one specific indication never implies approval or suitability for wellness, cosmetic, or anti-aging uses.

• It is a short synthetic peptide sequence.
• Interest largely traces to a small, older body of literature.

• Whether the reported findings hold up under modern, independent study.
• Safety with long-term or repeated use.

• Limited evidence means limited ability to weigh benefits against risks.
• Longevity marketing frequently overstates what small studies can show.

• What evidence supports this peptide for the goal I'm interested in?
• Is this peptide approved for this particular use?
• What benefits are supported by human evidence?
• What risks or side effects should I understand?
• What important unknowns remain?

• Overview literature relating to epitalon

  Placeholder — reputable reference to be added · Pending review

• Regulatory status information

  Placeholder — official regulatory source to be added · Pending review

Last reviewed: 2026-08-01